Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1
Completed
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Drug: HP518 - Dose EscalationDrug: HP518 - Dose expansion
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Hinova Pharmaceuticals Aus Pty Ltd
- Target Recruit Count
- 22
- Registration Number
- NCT05252364
- Locations
- 🇦🇺
Border Medical Oncology, Albury, New South Wales, Australia
🇦🇺Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
🇦🇺Macquarie University, Macquarie Park, New South Wales, Australia
News
No news found